Strategic Skills Synthesis & Value Proposition (2026)
Based on a detailed extraction from the Del Re portfolio (about.qmd, index.qmd, resume.qmd, services.qmd, portfolio.qmd), you possess a unique intersection of academic prestige and commercial engineering capability. This is rare and highly valuable.
The Core Asset Stack
- The “Prestige” Anchor:
- Ph.D. & Stanford Postdoc: This immediately bypasses HR filters and establishes absolute authority. You aren’t just a “data analyst”; you are a vetted scientist.
- 12,000+ Citations (Top 1% Global Impact): This is your ultimate social proof. It proves your methodologies are not just functional, but defining the standard in the field.
- Author of CRAN Packages (
compute.es): You don’t just use tools; you build the tools that other statisticians rely on.
- The “Technical” Engine (The Moat):
- Automated Intelligence (R & Quarto): Your ability to replace manual workflows (Excel/PPT) with code-first, reproducible pipelines that generate HTML/PDF dashboards in minutes. This is a massive cost-saving mechanism for enterprises.
- Advanced Longitudinal & Mixed-Effects Modeling (LMM/HLM): You move beyond group averages to understand individual trajectories. This is crucial for biotech, personalized medicine, and behavioral health.
- “N-of-1” Expertise: Proving product efficacy at the individual level—a massive selling point for modern health tech and CPG companies relying on Real-World Evidence (RWE).
- Meta-Analysis: The ability to synthesize complex, disparate evidence bases into definitive conclusions.
- The “Commercial” Translation:
- You bridge the gap between “academic rigor” (peer-review ready) and “commercial speed” (automated workflows). You turn raw data into “product efficacy engines.”
The $200/hr Value Proposition Shift
To command $200/hr, you must stop selling “hours of statistical analysis” and start selling Strategic Outcomes and Risk Mitigation.
Old Framing ($60/hr): “I can clean your data and run a mixed-effects model in R for your clinical trial.” (Commoditized labor)
New Framing ($200+/hr): “I architect automated Real-World Evidence (RWE) pipelines that prove your product’s efficacy to regulators and payers, reducing your reporting turnaround time by 98% and ensuring your methodology survives rigorous peer review.” (High-value strategic asset)